However, the core rationale for performing IgHr testing more broadly is that the BIRC3-MALT1 fusion gene is present in only a minority of gastric MALT lymphomas, with reported rates of approximately 24–32%33–35. The gene discussed is BIRC3; the disease is gastric mucosa-associated lymphoid tissue lymphoma.